drugset / Trial / NCT00516386
Safety Profile of Insulin Like Growth Factor-1 (IGF-I) Administration in Adolescents
NaSingle-groupOpen-labelOther
Summary
The purpose of this study was to determine whether giving insulin like growth factor-I (IGF-I) to adolescent low weight girls is safe and whether this increases levels of bone formation markers.
Timeline
- Start
- 2007-03
- Primary completion
- 2008-05
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | mecasermin | Protein / enzyme biologic | 35 ug/kg | Subcutaneous |
| Subject | mecasermin | Protein / enzyme biologic | 40 ug/kg | Subcutaneous |